A Phase II Trial OF Carboplatin, ABI-007 (Abraxane) And Sorafenib (BAY 43-9006) in Metastatic Melanoma

Clinical trial NCT00483301 · COMPLETED

Trial details

NCT number: NCT00483301
Sponsor: Mt. Sinai Medical Center, Miami
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Melanoma

Start date: 2007-05-01
Primary completion: 2009-08-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.